⌘+K

Pulse Explore Communities Researchers Journals

Browser extensionInstagram

Home Communities Explore

September 24, 2025Expert Review of Clinical PharmacologyOpen Access

N-methyl-D-aspartate receptor as a therapeutic target for burning mouth syndrome

Takahiko Nagamine

View Full Paper

Ask AI

Bookmark

Share

Key Points

N-methyl-D-aspartate receptor targeting shows potential to alleviate symptoms of burning mouth syndrome.
Key evidence suggests that treatment options like amitriptyline and gabapentin can be effective for patients experiencing nociplastic pain.
Analysis included various treatment approaches for burning mouth syndrome, utilizing insights from existing pharmacological studies.
Findings may enable improved therapeutic strategies for managing burning mouth syndrome and nociplastic pain in affected individuals.

Ask about this paper

Answers are grounded in this paper and cite their sources.

Ask your own question…

Implication

Observational analysis identifies N-methyl-D-aspartate receptor as crucial in burning mouth syndrome, suggesting new therapeutic approaches.

Abstract

KEYWORDS: amitriptylineburning mouth syndromeclonazepamgabapentinN-methyl-D-aspartate receptornociplastic pain

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Takahiko Nagamine (2025) studied this question.

synapsesocial.com/papers/68d6c682b1249cec298b265d https://doi.org/10.1080/17512433.2025.2566827

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 10 related papers. Consider them for comparative context:

1Burning Mouth Syndrome: Review of Current and Emerging Therapeutic StrategiesNarrative Review · 2026
2What’s Hot, What’s Not: Review of Pharmacological Options for Managing Burning Mouth Syndrome2025 · 2 citations
3Exploring the Therapeutic Potential of N-Methyl-D-Aspartate Receptor Antagonists in Neuropathic Pain Management2024 · 23 citations
4Amitriptyline effectiveness in burning mouth syndrome: An <scp>in‐depth</scp> case series analysis2024 · 9 citations
5Bridging Metabolomics and Nociception: The Arachidonic Acid–NMDA Receptor Axis in Burning Mouth SyndromeOriginal Research · 2026
6Burning Mouth Syndrome: A Narrative Review of Neurobiological Mechanisms and Management Strategies2025 · 9 citations
7EFFICACY OF DIFFERENT TOPICAL AMITRIPTYLINE CONCENTRATIONS IN THE TREATMENT OF PRIMARY BURNING MOUTH SYNDROME2025 · 2 citations
8Evaluating the Efficacy of Two Pharmaceutical Therapies for Burning Mouth Syndrome2024 · 1 citations
9Evaluating current and emerging pharmacological treatment options for men with androgenetic alopeciaExpert Review of Clinical Pharmacology · 2026
10Rethinking endpoints for anti-obesity pharmacotherapy in patients with hr+ early breast cancer receiving endocrine therapy: from body weight and BMI to body compositionExpert Review of Clinical Pharmacology · 2026

More from Expert Review of Clinical Pharmacology

More from Tokyo Medical and Dental University

More from Institute of Science Tokyo